<p>* In Delgard et al., 400.000IU/mL was used as cut-off for high and low viral load</p><p>Baseline characteristics of all randomized patients at study initiation.</p
<p>Baseline characteristics of patients randomized to receive atorvastatin or control.</p
<p>Baseline characteristics of the 1368 study patients and 150 healthy persons.</p
<p>Baseline characteristics of all patients who started treatment with PegIFN/RBV.</p
<p>Three patient groups, complete response with viral load <50 copies/ml, partial response with vira...
<p>Baseline clinical characteristics of the study patients with baseline HBV DNA ≥ 2000 IU /mL.</p
<p>The baseline calculated geometric mean (GM) viral load (VL), GM VL 95% confidence interval (CI), ...
<p>Data are presented as median (IQR) or percentage. Differences between groups were compared by Man...
<p>Values shown are medians (interquartile ranges) except where noted</p><p><sup>a</sup>Subjects wit...
<p>Baseline Characteristics of All Study Participants in 65 Colonies (32 in Influenza Vaccinated Gro...
<p>Demographic characteristics and baseline viral load and CD4 count for all patients on first-line ...
a<p>Values represent n (% with characteristic) or median (interquartile range).</p>b<p>Patient had a...
<p>Baseline demographic and laboratory characteristics of 363 HIV infected patients.</p
<p>Baseline characteristics of the 5,130 participants of the Prevention of Renal and Vascular End-St...
<p>Variables are expressed as median (interquartile range) or n (%).</p><p>NS, not significant; HBV,...
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Baseline characteristics of patients randomized to receive atorvastatin or control.</p
<p>Baseline characteristics of the 1368 study patients and 150 healthy persons.</p
<p>Baseline characteristics of all patients who started treatment with PegIFN/RBV.</p
<p>Three patient groups, complete response with viral load <50 copies/ml, partial response with vira...
<p>Baseline clinical characteristics of the study patients with baseline HBV DNA ≥ 2000 IU /mL.</p
<p>The baseline calculated geometric mean (GM) viral load (VL), GM VL 95% confidence interval (CI), ...
<p>Data are presented as median (IQR) or percentage. Differences between groups were compared by Man...
<p>Values shown are medians (interquartile ranges) except where noted</p><p><sup>a</sup>Subjects wit...
<p>Baseline Characteristics of All Study Participants in 65 Colonies (32 in Influenza Vaccinated Gro...
<p>Demographic characteristics and baseline viral load and CD4 count for all patients on first-line ...
a<p>Values represent n (% with characteristic) or median (interquartile range).</p>b<p>Patient had a...
<p>Baseline demographic and laboratory characteristics of 363 HIV infected patients.</p
<p>Baseline characteristics of the 5,130 participants of the Prevention of Renal and Vascular End-St...
<p>Variables are expressed as median (interquartile range) or n (%).</p><p>NS, not significant; HBV,...
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Baseline characteristics of patients randomized to receive atorvastatin or control.</p
<p>Baseline characteristics of the 1368 study patients and 150 healthy persons.</p
<p>Baseline characteristics of all patients who started treatment with PegIFN/RBV.</p